RT Journal Article
SR Electronic
T1 Enteral Access Potentially Endangers Esophageal Carcinoma Patients Under Multi-modality Therapy: A Population-based Study
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 2227
OP 2232
DO 10.21873/anticanres.13338
VO 39
IS 4
A1 CHUN-HOU HUANG
A1 TSUNG-CHENG HSIEH
A1 BEE-SONG CHANG
A1 TSO-FU WANG
A1 JUNG-LUN WU
A1 PI-CHUAN CHANG
A1 TAI-CHU PENG
YR 2019
UL http://ar.iiarjournals.org/content/39/4/2227.abstract
AB Background/Aim: This study aimed to evaluate the clinical outcome of esophageal cancer (EC) patients with enteral access (EA) undergoing multimodality therapy. Patients and Methods: This retrospective study analyzed data between 1997 and 2012 in Taiwan using the National Health Insurance Research Database. Patients with newly-diagnosed EC undergoing multimodality therapy were identified and classified as either EA group or no-EA group. Results: The mortality incidence of EC patients with EA was significantly higher than in no-EA patients. The Cox model revealed the EA group had a higher risk of mortality than the no-EA group. Patients with chronic obstructive pulmonary disease (COPD) were at significantly higher risk of mortality compared to patients without COPD. Conclusion: EA in EC patients undergoing multimodality therapy was associated with an increased risk of mortality.